Your browser doesn't support javascript.
loading
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi, Sudhir Pai; Kozlowski, Pamela A; Nakaya, Helder I; Burger, Matheus C; Russo, Pedro; Pham, Mathew; Kovalenkov, Yevgeniy; Silveira, Eduardo L V; Havenar-Daughton, Colin; Burton, Samantha L; Kilgore, Katie M; Johnson, Mathew J; Nabi, Rafiq; Legere, Traci; Sher, Zarpheen Jinnah; Chen, Xuemin; Amara, Rama R; Hunter, Eric; Bosinger, Steven E; Spearman, Paul; Crotty, Shane; Villinger, Francois; Derdeyn, Cynthia A; Wrammert, Jens; Pulendran, Bali.
Afiliação
  • Kasturi SP; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Kozlowski PA; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
  • Nakaya HI; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Burger MC; Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.
  • Russo P; Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.
  • Pham M; Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.
  • Kovalenkov Y; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Silveira ELV; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Havenar-Daughton C; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Burton SL; Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.
  • Kilgore KM; Division of Vaccine Discovery, La Jolla Institute of Allergy and Immunology, La Jolla, California, USA.
  • Johnson MJ; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Nabi R; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Legere T; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Sher ZJ; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
  • Chen X; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Amara RR; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Hunter E; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Bosinger SE; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Spearman P; Division of Microbiology and Immunology, Emory University, Rollins Research Center, Atlanta, Georgia, USA.
  • Crotty S; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Villinger F; Department of Pathology and Laboratory Medicine, Atlanta, Georgia, USA.
  • Derdeyn CA; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Wrammert J; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.
  • Pulendran B; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
J Virol ; 91(4)2017 02 15.
Article em En | MEDLINE | ID: mdl-27928002
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Vacinas contra a SAIDS / Nanopartículas / Anticorpos Antivirais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Vacinas contra a SAIDS / Nanopartículas / Anticorpos Antivirais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article